Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LEGN | AZN | AMGN | GILD | VRTX |
| Company | Legend Biotech Corp ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 34.43 | 70.40 | 281.12 | 105.68 | 494.26 |
| High | 35.24 | 72.06 | 289.90 | 107.17 | 506.96 |
| Low | 34.22 | 69.71 | 279.06 | 104.11 | 490.85 |
| Last | 34.43 | 71.71 | 288.56 | 104.21 | 503.50 |
| Change | -0.27 | +1.78 | +5.47 | -2.13 | +7.01 |
| % Change | -0.78% | +2.55% | +1.93% | -2.00% | +1.41% |
| Volume | 702,900 | 7,919,000 | 2,147,700 | 7,646,300 | 1,254,900 |
| 20-Day Average Volume | 1,585,715 | 7,173,135 | 3,193,680 | 9,863,810 | 1,676,165 |
| Previous Close | 34.70 | 69.93 | 283.09 | 106.34 | 496.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.84 | 68.52 | 287.84 | 105.97 | 486.69 |
| 20-Day Raw Stochastic | 85.31% | 72.41% | 44.55% | 50.70% | 94.12% |
| 20-Day Relative Strength | 50.66% | 53.14% | 47.30% | 46.33% | 57.30% |
| Weighted Alpha | -26.72 | -6.03 | -8.10 | +54.90 | +23.04 |
| Today's Opinion | 88% Sell | 24% Sell | 40% Sell | 40% Buy | 56% Buy |
| Previous Opinion | 88% Sell | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 24% Buy | 32% Buy | 80% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.15% since 04/22/25 | +5.66% since 04/22/25 | +3.65% since 04/22/25 | -1.23% since 04/22/25 | +2.66% since 04/22/25 |
| Low | 33.66 on 04/25/25 | 68.36 on 04/23/25 | 274.42 on 04/24/25 | 93.37 on 04/25/25 | 484.50 on 04/25/25 |
| High | 35.32 on 04/23/25 | 72.06 on 04/29/25 | 289.90 on 04/29/25 | 107.56 on 04/24/25 | 506.96 on 04/29/25 |
| 1-Month | |||||
| %Chg | -1.80% since 03/28/25 | -2.82% since 03/28/25 | -5.99% since 03/28/25 | -6.78% since 03/28/25 | +2.19% since 03/28/25 |
| Low | 29.27 on 04/09/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 448.14 on 04/07/25 |
| High | 35.32 on 04/23/25 | 75.70 on 04/03/25 | 315.00 on 03/31/25 | 114.75 on 04/03/25 | 506.96 on 04/29/25 |
| 3-Month | |||||
| %Chg | -4.63% since 01/29/25 | +2.08% since 01/29/25 | +2.44% since 01/29/25 | +9.02% since 01/29/25 | +14.04% since 01/29/25 |
| Low | 29.27 on 04/09/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 435.00 on 01/30/25 |
| High | 40.00 on 02/21/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -24.26% since 10/29/24 | -4.67% since 10/29/24 | -8.68% since 10/29/24 | +18.31% since 10/29/24 | +7.05% since 10/29/24 |
| Low | 29.27 on 04/09/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 47.79 on 11/05/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,372,621 | 216,870,208 | 152,203,616 | 132,410,632 | 127,638,144 |
| Shares Outstanding, K | 183,649 | 3,101,247 | 537,651 | 1,245,163 | 257,081 |
| Annual Sales | 627,240,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -177,030,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 186,520,000 | 14,891,000,000 | 9,086,000,000 | 6,667,000,000 | 2,912,000,000 |
| Last Quarter Net Income | 26,280,000 | 1,499,000,000 | 627,000,000 | 1,315,000,000 | 913,000,000 |
| 60-Month Beta | 0.21 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 03/11/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.81 on 04/24/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/12/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.93 | 14.17 | 13.33 | 0.00 |